Weeding Out the Winners in Race for Cannabis-Based Drugs
“I Want to Take You Higher.”
Pharmaceutical companies developing cannabis-based drugs just might be serenading investors with this 1969 hit single by the group Sly and the Family Stone.
But a word of caution to those banking on marijuana drugs to be the blockbusters that send share prices zooming. You could see your investment “go to pot.”
That’s because a lot of heavy lifting still needs to be done before marijuana proves its medical mettle. Look no further than in an editorial titled “Medical Marijuana: Is the Cart Before the Horse?”, which appeared in the Journal of the American Medical Association last year. The two authors, researchers at the department of psychiatry at the Yale School of Medicine, said the evidence favoring the use of marijuana for medical conditions is insufficient, of poor quality and fails to meet FDA standards.
Among the host of pharmaceutical companies striving to provide the...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin